A team of Hebrew University of Jerusalem scientists used an award-winning algorithm to identify 27 molecules with the significant potential for the treatment of obesity, fatty liver disease, among other ailments.
In a newly published study in Scientific Reports, a team from Hebrew University of Jerusalem’s Institute for Drug Research reports its discovery of 27 new molecules that activate a protein called PPAR-delta, which has the potential to increase physical endurance and trim waistlines by getting muscle cells to burn more fat.
These molecules therefore hold promise for the treatment of fatty liver disease and obesity, among other ailments. Continue Reading »